SBIR Phase II: Microchip Assay for Glycosylated Hemoglobin

Award Information
Agency:
National Science Foundation
Branch
n/a
Amount:
$468,024.00
Award Year:
2006
Program:
SBIR
Phase:
Phase II
Contract:
0548744
Award Id:
68642
Agency Tracking Number:
0419441
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
P O Box 272908, Fort Collins, CO, 80525
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Dale Willard
Dr
(970) 402-3117
dale.willard@colostate.edu
Business Contact:
Dale Willard
Dr
(970) 491-4064
dale.willard@colostate.edu
Research Institution:
n/a
Abstract
This Small Business Innovation Research (SBIR) Phase II project aims at developing the next generation of diabetic monitoring devices that will allow the measurement of multiple markers of disease regulation and progression using an innovative lab-on-a-chip technology. The project will develop the first integrated microchip CE device for measurement of an important maker of diabetes.

This technology will impact patient monitoring for disease progression and therapeutic efficacy by following biomarker more efficiently as well as being used at the point of care. This eliminates the time and cost currently required to perform follow up laboratory tests. The technology approaches the chemistry of biomarkers from a non-traditional sensor mechanism and shows great promise for the detection and use of biomarkers for specific diseases.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government